Recommended Daily Dose of Sumatriptan for Migraine Treatment
The maximum daily dose of sumatriptan for migraine treatment is 200 mg in a 24-hour period. 1
Dosing Guidelines
Initial Dosing
- The recommended single dose options are:
- 25 mg orally
- 50 mg orally
- 100 mg orally 1
Dose Selection Considerations
- 50 mg and 100 mg doses may provide greater effect than 25 mg
- 100 mg may not provide additional benefit over 50 mg
- Higher doses carry increased risk of adverse reactions 1
- The 50 mg dose likely offers the best effectiveness-to-tolerability ratio 2
Repeat Dosing
- If migraine hasn't resolved after 2 hours or returns after temporary improvement, a second dose may be administered
- Must wait at least 2 hours between doses
- Total daily dose should not exceed 200 mg in a 24-hour period 1
Special Populations
- For patients with mild to moderate hepatic impairment:
Alternative Administration Routes
- Subcutaneous injection: 6 mg, may be repeated after 1 hour if needed, maximum 12 mg per 24 hours
- Intranasal: 5-10 mg (1-2 sprays) in one nostril, may be repeated after 2 hours, maximum 40 mg per day 3
Efficacy Considerations
- Treating during mild pain phase provides better outcomes than waiting until pain is moderate or severe 3
- Subcutaneous administration achieves headache relief at 1 hour in 70-82% of patients 3
- The safety of treating more than 4 headaches in a 30-day period has not been established 1
Contraindications
Sumatriptan is contraindicated in:
- Ischemic heart disease
- Coronary artery disease
- Uncontrolled hypertension
- Hemiplegic or basilar migraine
- Use within 24 hours of another triptan or ergotamine-containing medication
- Use of MAO inhibitors
- Severe hepatic impairment
- Pregnancy 3
Common Pitfalls and Caveats
- Approximately 40% of patients who initially respond may experience headache recurrence within 24 hours 4
- Sumatriptan should not be given during the migraine aura 4
- Patients should try a medication for 2-3 headache episodes before determining its effectiveness 3
- Adverse events are typically transient and mild, with a clear dose-response relationship (25 mg to 100 mg) 5
- Common side effects include injection site reactions (with subcutaneous form), nausea, vomiting, malaise, fatigue, and dizziness 4
- Chest symptoms occur in 3-5% of patients and require careful monitoring 4